Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3015 USD | +3.68% |
|
+5.68% | -33.74% |
Evolution of the average Target Price on Galmed Pharmaceuticals Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Galmed Pharmaceuticals Ltd.
Maxim | |
Canaccord Genuity | |
Cantor Fitzgerald | |
Raymond James | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- GLMD Stock
- Consensus Galmed Pharmaceuticals Ltd.